Performing highthroughput screening on glioma samples followed by pan-molecular profiling to establish drug/drug class-specific resistance and sensitivity markers. Molecular characterization of primary brain tumors in underserved minority groups. Characterization of circularing biomarkers in glioma patients. Growing brain tumor clinical trial portfolio.
![](https://cancer.uillinois.edu/wp-content/uploads/2023/09/adaher.png)
Ahmad Daher, PhD, MD, MS
Assistant Professor
Department of Neurology
College of Medicine
Research Program
Translational Oncology Program (TO)
Phone: (202) 297-3675
Email: [email protected]